Ignite Creation Date:
2024-05-06 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05215106
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2021-12-22
Brief Title:
Short-term Pre-OPerative Durvalumab MEDI 4736 in Early Small Triple Negative Breast Cancer Patients POP-Durva
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-22
First Submit QC Date:
January 17 2022
Study First Post Date:
2022-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-04
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL